Mauro Ceroni

Disease clustering: the example of ALS, PD, dementia and hereditary ataxias in Italy.

Detection of paraneoplastic anti-neuronal-specific antibodies: comparison of different immunohistochemical techniques.

The immunobiology of malignant gliomas.

Antibodies to cerebellar nerve fibres in two patients with paraneoplastic cerebellar ataxia.

Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors.

Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encephalomyelitis.

2-DE and MALDI-TOF-MS for a comparative analysis of proteins expressed in different cellular models of amyotrophic lateral sclerosis.

Optimizing separation efficiency of 2-DE procedures for visualization of different superoxide dismutase forms in a cellular model of amyotrophic lateral sclerosis.

Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response.

Cerebrospinal BAFF and Epstein-Barr virus-specific oligoclonal bands in multiple sclerosis and other inflammatory demyelinating neurological diseases.

NGF and heart: Is there a role in heart disease?

Screening of the PFN1 gene in sporadic amyotrophic lateral sclerosis and in frontotemporal dementia.

Acute late-onset encephalopathy after radiotherapy: an unusual life-threatening complication.

Posttranscriptional regulation of SOD1 gene expression under oxidative stress: Potential role of ELAV proteins in sporadic ALS.

Altered intracellular localization of SOD1 in leukocytes from patients with sporadic amyotrophic lateral sclerosis.

Facing contrast-enhancing gliomas: perfusion MRI in grade III and grade IV gliomas according to tumor area.

Lower motor neuron disease with respiratory failure caused by a novel MAPT mutation.

Herpes simplex encephalitis in glioma patients: a challenging diagnosis.

Meningeal melanomatosis: a challenge for timely diagnosis.

TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations.

Good outcome in adult-onset Rasmussen's encephalitis syndrome: is recovery possible?

Hydrogen peroxide-mediated induction of SOD1 gene transcription is independent from Nrf2 in a cellular model of neurodegeneration.

Communication and pragmatic breakdowns in amyotrophic lateral sclerosis patients.

Amyotrophic lateral sclerosis and environmental factors.

"Malignant" foot drop: Enzinger epithelioid sarcoma of the common fibular nerve.

Predictors of outcome in a large retrospective cohort of patients with transverse myelitis.

Long non-coding and coding RNAs characterization in Peripheral Blood Mononuclear Cells and Spinal Cord from Amyotrophic Lateral Sclerosis patients.

Lymphoblastoid cell lines as a model to understand amyotrophic lateral sclerosis disease mechanisms.

A motor neuron strategy to save time and energy in neurodegeneration: adaptive protein stoichiometry.

Lower motor neuron syndrome in a patient with HER2-positive metastatic breast cancer: A case report and review of the literature.

Pathological Proteins Are Transported by Extracellular Vesicles of Sporadic Amyotrophic Lateral Sclerosis Patients.

Role of Cerebrospinal Fluid Biomarkers and (18)F-florbetapir PET Imaging in the Diagnosis of Primary Progressive Aphasia: A Retrospective Analysis.

RNA-Seq profiling in peripheral blood mononuclear cells of amyotrophic lateral sclerosis patients and controls.

From brain collections to modern brain banks: A historical perspective.

Early cortical and late striatal diffusion restriction on 3T MRI in a long-lived sporadic creutzfeldt-jakob disease case.

Leukocyte Derived Microvesicles as Disease Progression Biomarkers in Slow Progressing Amyotrophic Lateral Sclerosis Patients.

Nuclear Phospho-SOD1 Protects DNA from Oxidative Stress Damage in Amyotrophic Lateral Sclerosis.

Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS).

Reversible Holmes Tremor due to Middle Cerebral Artery Giant Aneurysm.